| Authors: |
Hardet R; University Rouen Normandie, INSERM, Normandie University, PANTHER, UMR 1234, 76000 Rouen, France., Wang SH; Topas Therapeutics GmbH, Hamburg, Germany., Delignat S; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, CNRS, Sorbonne Université, Université de Paris, 75006 Paris, France., Blandin M; University Rouen Normandie, INSERM, Normandie University, PANTHER, UMR 1234, 76000 Rouen, France., Digigow R; Topas Therapeutics GmbH, Hamburg, Germany., Gottwick C; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Heine M; Department of Biochemistry and Molecular Cell Biology (N30), University Medical Clinic Hamburg-Eppendorf, Hamburg, Germany., Marques Mesquita LM; Topas Therapeutics GmbH, Hamburg, Germany., Fanzutti M; Topas Therapeutics GmbH, Hamburg, Germany., Vocaturo AL; Topas Therapeutics GmbH, Hamburg, Germany., Mungalpara D; Topas Therapeutics GmbH, Hamburg, Germany., Boyer O; University Rouen Normandie, INSERM, Normandie University, PANTHER, UMR 1234, 76000 Rouen, France; Department of Immunology and Biotherapy, CHU de Rouen, Rouen, France., Lacroix-Desmazes S; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, CNRS, Sorbonne Université, Université de Paris, 75006 Paris, France., Fleischer S; Topas Therapeutics GmbH, Hamburg, Germany. Electronic address: fleischer@topas-therapeutics.com., Adriouch S; University Rouen Normandie, INSERM, Normandie University, PANTHER, UMR 1234, 76000 Rouen, France. Electronic address: sahil.adriouch@univ-rouen.fr. |
